Related by context. All words. (Click for frequent words.) 85 mm Hg 75 mm Hg systolic 73 mg dL 72 mmHg systolic 72 systolic BP 71 mg dl 71 #mmHg [002] 70 mmHg diastolic 70 #mmHg [001] 70 systolic 69 systolic blood pressure 69 mm Hg diastolic 69 diastolic blood pressure 68 #/#mmHg 68 mmol l 67 diastolic BP 67 diastolic pressure 67 antihypertensive medications 66 HbA1c levels 66 #mm Hg 66 HbA 1c 66 #.#/#.# mm Hg [002] 65 mL/min/#.# m 2 65 serum potassium 65 HbA1c 65 #.#mmHg 64 #.#/#.# mmHg [001] 64 normotensive 64 Hb A1C 64 creatinine clearance 64 ng mL 63 A1C levels 63 pg mL 63 g dL 62 ng dL 62 fasting blood glucose 62 mL kg 62 baseline HbA1c 62 sUA 62 #mg/dL [001] 62 hemoglobin A1c HbA1c 62 fasting plasma glucose 62 mL min 62 systolic pressure 62 diastolic blood pressures 62 hemoglobin A1c levels 62 LDL C 62 #.#mmol L [002] 62 lispro 61 #.#/#.# mm Hg [003] 61 proteinuria 61 CrCl 61 mmol L 61 pulmonary capillary wedge 61 -#.# mg dL [002] 61 LVEF 61 #.#mg/dL 61 #mg/dl 61 fasting glucose 61 mEq L 61 systolic diastolic 61 HbA1C 61 g dl 60 glycated hemoglobin HbA1c 60 hypertensive patients 60 fraction LVEF 60 serum phosphorus 60 glycated hemoglobin 60 nondiabetic patients 60 HbA 1c levels 60 Cmax 60 mg d 60 binary restenosis 60 hypertensives 60 ml min 60 A1C 60 PaO 2 60 ng ml 60 nmol L 59 diastolic 59 Diastolic 59 fasting plasma glucose FPG 59 #mg/dL [002] 59 BENICAR 59 pulmonary arterial 59 cholesterol LDL C 59 HbA1C levels 59 mg BID 59 #.#/#.# mm Hg [001] 59 MADRS score 59 glycated hemoglobin levels 59 mmHg p = 59 valsartan 59 A1c levels 58 #mg/day [001] 58 x ULN 58 plasma glucose 58 Intraocular pressure 58 nicardipine 58 plasma glucose levels 58 mmol L. 58 fasting triglyceride levels 58 mIU L 58 pg ml 58 glycemia 58 serum uric acid 58 ng dl 58 mL/min/#.# m2 58 P = .# 58 CDAI score 58 lumbar spine BMD 58 serum creatinine levels 58 ABPM 58 eGFR 58 insulin detemir 58 irbesartan 58 -#.# mm Hg 58 μmol L 58 ejection fractions 58 systolic blood pressures 58 apnea hypopnea index 58 systolic dysfunction 57 Diastolic pressure 57 serum urate 57 n = 57 per deciliter mg 57 mcg kg 57 HBeAg seroconversion 57 mmol liter 57 prehypertensive 57 CI -#.# 57 hemoglobin A1C 57 intima media thickness 57 nmol liter 57 total cholesterol triglycerides 57 ml kg 57 NATRECOR R 57 mmol 57 fasting glucose levels 57 highest tertile 57 creatinine levels 57 allopurinol 57 glycosylated hemoglobin HbA1c 57 leukocyte count 57 urinary albumin 57 pmol L 57 oral antidiabetic medication 57 -#.# mmHg 57 CK MB 57 alanine aminotransferase 57 albumin excretion rate 57 umol L 57 mcg BID 57 #.#ng/ml 57 antihypertensive therapy 57 statin monotherapy 56 glimepiride 56 creatinine ratio 56 candesartan 56 sUA levels 56 systolic diastolic blood 56 normal ULN 56 aspartate aminotransferase AST 56 amlodipine 56 mg QD 56 gastric pH 56 tirofiban 56 serum triglycerides 56 log# copies mL 56 NPH insulin 56 A1c 56 oxycodone CR 56 % CI #.#-#.# [003] 56 #.#mmol l [002] 56 glomerular filtration rate 56 interquartile range 56 alanine aminotransferase ALT 56 glycosylated hemoglobin 56 postprandial glucose 56 mcg mL 56 serum phosphate levels 56 mg TID 56 LDL triglycerides 56 adjunctive placebo 56 lopinavir r arm 56 % CI #.#-#.# [006] 56 μg L 56 SBP DBP 56 REYATAZ r arm 56 p = #.# [002] 56 % Confidence Interval 56 -#.# ± [002] 56 sodium excretion 56 μg mL 56 #.#mmol L [001] 56 serum sodium 56 benazepril 56 mg tid 56 DAS# [002] 56 serum testosterone 56 severe exacerbations 56 UACR 56 Systolic 56 resistant hypertension 56 HOMA IR 56 OGTT 56 kg/m2 56 total cholesterol LDL 56 serum urate levels 56 lowest tertile 56 glomerular filtration 56 tapentadol ER 56 FEV1 55 nonfasting triglyceride levels 55 diastolic hypertension 55 serum magnesium 55 Systolic blood pressure 55 peak VO2 55 μg kg 55 BENICAR HCT 55 neutrophil counts 55 Apidra ® 55 baseline serum creatinine 55 serum phosphorous 55 triacylglycerol concentrations 55 biphasic insulin aspart 55 mIU ml 55 ATACAND 55 baseline A1C 55 albumin excretion 55 candesartan cilexetil 55 hemoglobin A1c 55 psia 55 moderate renal impairment 55 achieved ACR# 55 urinary sodium excretion 55 nondiabetic 55 recurrent VTE 55 incontinence episodes 55 p = #.# [004] 55 aminotransferases 55 elevated LDL cholesterol 55 triglyceride levels 55 Index CDAI score 55 kPa 55 ramipril 55 prehypertension 55 abacavir lamivudine 55 HCTZ 55 LDL cholesterol levels 55 nondiabetics 55 -#.# mg dL [001] 55 lopinavir r 55 % CI #.#-#.# [004] 55 diameter stenosis 55 arterial stiffness 55 dapagliflozin plus 55 ejection fraction 55 urinary albumin excretion 55 iPTH 55 angiotensin II receptor blockers 55 severe renal impairment 55 QTcF 54 ACE inhibitor perindopril 54 urine albumin 54 serum triglyceride levels 54 hemoglobin Hb 54 copies mL 54 ventricular ejection fraction 54 IIIa inhibitors 54 log# IU mL 54 intraocular pressure 54 #mg BID [003] 54 mIU mL 54 hours postdose 54 aspartate aminotransferase 54 serum creatinine 54 -#.# mmol L 54 serum phosphate 54 antihypertensive medication 54 mU L 54 -#.# ± [001] 54 infarct size 54 lipid levels 54 confidence interval CI 54 postop 54 hyperlipidaemia 54 μg dL 54 LV dysfunction 54 mean baseline HbA1c 54 nonobese 54 mU liter 54 NSTE ACS 54 β blocker 54 hemoglobin concentrations 54 PSA nadir 54 mg dose 54 diuretic chlorthalidone 54 luminal diameter 54 serum cortisol 54 placebo 54 kg m² 54 ug kg 54 diastolic pressures 54 serum calcium 54 fasting insulin 54 mcg QD 54 Crohn Disease Activity 54 plasma HCV RNA 54 mg simvastatin 54 baseline Hb 54 budesonide pMDI 54 systolic hypertension 54 placebo p 54 4mg/kg 54 hip BMD 54 peginterferon alfa 2a 54 plasma triglycerides 53 p = .# [002] 53 serum phosphorus levels 53 % CI #.#-#.# [007] 53 ritonavir boosted 53 troponin T 53 lowering systolic blood 53 intraocular pressure IOP 53 μg liter 53 supine systolic 53 placebo p = 53 estimated glomerular filtration 53 Hb A1c 53 hsCRP levels 53 adjunctive ABILIFY 53 MMSE score 53 μg 53 antihypertensive agents 53 mL sec 53 PREZISTA ritonavir 53 titrated 53 tipranavir r 53 #OHD levels 53 mg qd 53 nmol 53 plasma concentrations 53 asymptomatic carotid stenosis 53 serum concentrations 53 ± 53 albuminuria 53 statistically significant p = 53 CK # plasma concentrations 53 left ventricular systolic 53 β blockers 53 angiotensin converting enzyme 53 plasma urate 53 nonobstructive CAD 53 active comparator 53 pulmonary artery pressure 53 nadolol 53 Fasting glucose 53 % CI #.#-#.# [002] 53 CDAI 53 thiazide diuretics 53 rimonabant #mg 53 SGOT 53 Atacand 53 titrated glipizide plus 53 μg dose 53 #mg/day [002] 53 serum IGF 53 triglyceride TG 53 #mg doses [002] 53 atorvastatin #mg 53 Score DAS# 53 Target Lesion Revascularization TLR 53 TMC# r 53 microalbuminuria 53 serum HBV DNA 53 unfractionated heparin 53 LANTUS R 53 hypertension 53 insulin glargine 53 log# 53 Ambulatory Blood Pressure 53 fluticasone salmeterol 53 tertile 53 mEq 53 normothermic 53 Serum creatinine 53 mg/m2 dose 53 cm H2O 53 CRESTOR #mg 53 sulphonylurea 53 IU mL 53 IPSS 53 mg Lucentis 53 hyperphenylalaninemia HPA due 53 systemic embolism 53 certolizumab 53 refractory ischemia 53 XIENCE V PROMUS Stent 52 adiponectin concentrations 52 postprandial blood glucose 52 asthma exacerbation 52 hypopneas 52 periprocedural 52 hypertensive 52 arterial oxygen saturation 52 EDSS score 52 Monitoring ABPM 52 pioglitazone 52 glulisine 52 comparator arm 52 -8 -9 52 biochemical recurrence 52 p = NS 52 labetalol 52 eptifibatide 52 plus methotrexate 52 postintervention 52 postprandial glucose PPG 52 Lantus ® 52 SpO 2 52 PRADAXA #mg 52 PASI scores 52 μmol l 52 nmol l 52 fasting triglycerides 52 oxycodone IR 52 HCV RNA 52 plasma uric acid 52 metoprolol tartrate 52 TAXUS Express Stent 52 NYHA class 52 Hb levels 52 serum glucose 52 CI #.#-#.# [001] 52 nanograms per 52 Hb 52 detemir 52 mg BID dose 52 methacholine challenge 52 #mg [003] 52 virologic failure 52 % CI #.#-#.# [008] 52 thromboembolic events 52 urate lowering therapy 52 Psoriasis Area 52 LEXIVA 52 nonfatal myocardial infarction 52 intact parathyroid hormone 52 #ug [001] 52 thyroid stimulating hormone 52 HBV DNA levels 52 NovoLog ® Mix 52 beta blocker therapy 52 nitroprusside 52 min -1 52 Prehypertension 52 serum bilirubin 52 telmisartan 52 post prandial glucose 52 plus GP IIb 52 platelet inhibition 52 oxygen saturation 52 kilopascals 52 calculated creatinine clearance 52 hs CRP 52 Lucentis monotherapy 52 distensibility 52 expiratory 52 oral antidiabetes 52 noninferiority 52 postoperatively 52 plasma renin activity 52 endarterectomy 52 p = 52 undetectable viral 52 primary hypercholesterolemia 52 triglycerides TG 52 ALT elevation 52 eplerenone 52 CC genotype 52 flow mediated dilation 52 nonsignificant difference 52 chlorambucil 52 copies ml 52 statistical significance p 52 paricalcitol 52 olmesartan 52 X ULN 52 placebo PBO 52 telaprevir dosed 52 abciximab 52 mineral density 52 creatinine 52 MBq 52 lactate dehydrogenase LDH 52 mL 52 blood Phe levels 52 IFN alfa 52 -#.# log# 52 left ventricular dysfunction 52 nonfasting 52 lispro alone 52 μg ml 52 confidence interval #.#-#.# 52 PCWP 52 endometrial thickness 52 desvenlafaxine succinate 52 rosuvastatin #mg 52 oral glucose tolerance 52 sodium nitroprusside 52 postprocedure 52 SGPT 52 antihypertensive drugs 52 hydroxyvitamin D levels 52 cardiovascular morbidity 52 pulmonary exacerbation 52 transaminases 52 HBV DNA 52 metformin sulphonylurea 51 isolated systolic hypertension 51 hypokalemia 51 undetectable HBV DNA 51 rizatriptan 51 MMSE scores 51 preoperatively 51 injectable emulsion 51 mg dosed 51 Hemoglobin A1c 51 mcg dL 51 chlorthalidone 51 macrovascular 51 OADs 51 transferrin saturation 51 definite stent thrombosis 51 p ≤ 51 microg 51 dose atorvastatin 51 kg -1 51 serum lipid levels 51 atazanavir ritonavir 51 detrusor 51 elevated creatinine 51 hsCRP 51 serum LDL cholesterol 51 CR nPR 51 angiotensin converting enzyme inhibitor 51 unfractionated heparin UFH 51 aliskiren 51 bad cholesterol LDL 51 salivary flow 51 lung function 51 mg 51 blood glucose concentrations 51 PREZISTA r arm 51 corrected QT interval 51 serum TSH 51 ACE inhibitor 51 serum HCV RNA 51 mercury mm Hg 51 specific antigen PSA 51 QTc interval 51 sd = 51 infliximab monotherapy 51 oral allopurinol 51 test OGTT 51 mm Hg millimeters 51 advanced adenomas 51 plasma homocysteine 51 bezafibrate 51 dose clopidogrel 51 mild renal impairment 51 serum calcium levels 51 baseline FEV1 51 nonfatal MI 51 flutamide 51 #mg dose [003] 51 receiving ISENTRESS 51 IRLS score 51 tamsulosin 51 Triglyceride levels 51 leukopenia 51 target vessel revascularization 51 IELT 51 tolterodine ER 51 ≥ 51 myocardial infarction MI 51 LPV r 51 reinfarction 51 atheroma volume 51 LV ejection fraction 51 reintervention 51 subclinical hypothyroidism 51 glycosylated hemoglobin levels 51 APTIVUS r 51 annualized relapse 51 urinary oxalate 51 salmeterol fluticasone propionate 51 hypotension 51 aminotransferase ALT 51 #μg [001] 51 CD4 + cell 51 Diastolic blood pressure 51 fasting serum 51 mol L 51 elevated serum creatinine 51 Index CDAI 51 thyroxine 51 Left Ventricular Ejection Fraction 51 fatal myocardial infarction 51 thyrotropin levels 51 Pred Forte 51 administered subcutaneously 51 losartan 51 evaluable subjects 51 carotid IMT 51 ULORIC 51 morphometric vertebral fractures 51 diastolic function 51 microvascular complications 51 hypophosphatemia 51 tPSA 51 RLAI 51 target lesion revascularization 51 serum ALT 51 serum triglyceride 51 mCi kg 51 left ventricular hypertrophy 51 tHcy 51 mild renal insufficiency 51 creatine phosphokinase 51 ventricular mass 51 diastolic readings 51 azilsartan medoxomil 51 ‰ ¥ 51 stable angina 51 pCR 51 mg orally 51 triglycerides ≥ 51 apolipoprotein B 51 Knodell necroinflammatory score 51 pretreatment baseline 51 LEXIVA r 51 undetectable viral load 51 ACE inhibitor ramipril 51 hypoglycemic events 51 angiotensin receptor blocker 51 serum potassium levels 51 IIIa inhibitor 51 mg kg dose 51 antibody titer 51 achieved statistical significance 51 echocardiographic parameters 51 mm3 51 elevated IOP 51 Taxus Stent 51 enoxaparin 51 valsartan amlodipine 51 baseline LDH 51 metformin monotherapy 51 clinically meaningful reductions 51 aminotransferase levels 51 μg doses 51 nonfatal stroke 51 5-FU/LV 51 dose colchicine 51 HAM D# scores 51 kcal d 51 NNT = 51 #μg [002] 51 blood Phe 51 rapid virological response 51 LDL 51 statistically significant p 51 mediated dilation 51 metformin sulfonylurea 51 cerebrovascular events 51 MACCE 51 anemia hemoglobin 51 euthyroid 51 pmol liter 50 aminotransferase elevations greater 50 glargine 50 prolactin levels 50 IOP lowering 50 blood oxygen saturation 50 QRS duration 50 gout flares 50 bronchodilation 50 arterial thromboembolic events 50 hemoglobin concentration 50 IFN α 50 coronary revascularization 50 severe hypoglycemic 50 AVODART 50 serum leptin 50 fractional shortening 50 arteriolar 50 D dimer 50 mercury mmHg 50 mg hydrochlorothiazide 50 oxygen desaturation 50 angiotensin II receptor blocker 50 milligrams mg 50 preintervention 50 elevated uric acid 50 antihypertensives 50 extrapyramidal symptoms 50 IFN beta 50 -#.# log# copies mL 50 = #.#-#.# 50 urinary protein 50 thickness CIMT 50 FOLFOX4 50 Ejection Fraction 50 mcg 50 IU ml 50 biochemical relapse 50 serum cholesterol 50 + PH# 50 ACR# response 50 diopters 50 lipid parameters 50 protein excretion 50 residual platelet reactivity 50 triglyceride concentrations 50 hemodynamic parameters 50 NYHA functional class 50 systemic corticosteroid 50 estimated GFR 50 mg kg 50 NT proBNP 50 median PFS 50 titrated glipizide 50 serum testosterone levels 50 ejection fraction EF 50 tolvaptan 50 ppO2 50 basal bolus therapy 50 mmHg p 50 platelet reactivity 50 cells uL 50 bypass graft CABG surgery 50 nocturnal hypoglycaemia 50 procalcitonin 50 primary aldosteronism 50 ipsilateral stroke 50 Ramipril 50 paroxysmal AF 50 severe neutropenia 50 nocturnal awakenings 50 fructose diet 50 mean baseline A1C 50 index BMI 50 cerebral perfusion 50 CYPHER Stent 50 Lantus R 50 glipizide 50 elevated triglyceride levels 50 PREZISTA r 50 plasma renin 50 phonophobia 50 CNS LS 50 fasting plasma 50 8mg/kg 50 serum CRP 50 mg ustekinumab 50 inadequate glycemic 50 urinary N telopeptide 50 splenectomized 50 cGy 50 mcg kg min 50 Â ± 50 C reactive protein 50 μg d 50 mg kg hr 50 TAXUS p value 50 cilostazol 50 dobutamine 50 posttransplant 50 patients undergoing CABG 50 confidence intervals CIs 50 ± SD 50 recurrent atrial fibrillation 50 orthostatic 50 subcutaneous insulin 50 liver histology 50 esomeprazole 50 HbA 1C 50 ADCS ADL 50 Baseline characteristics 50 #mg QD [002] 50 cm2 50 6MWD 50 fluvastatin 50 amoxicillin clavulanate 50 tenecteplase 50 undetectable HCV RNA 50 hemodilution 50 Lp PLA2 50 nanomoles per 50 NIHSS 50 ARCOXIA 50 steroid dexamethasone 50 angina chest 50 cardiovascular mortality 50 ropivacaine 50 perioperative complications 50 severe obstructive sleep 50 Hazard Ratio HR 50 adenoma recurrence 50 noninferior 50 serum PSA 50 tacrolimus 50 bypass grafting 50 elevated ALT 50 Hemoglobin A1c HbA1c 50 urinary cortisol 50 #mg q8h 50 orthostatic hypotension 50 elevated fasting glucose 50 salmeterol fluticasone 50 myocardial infarction stroke 50 #-# mg dL 50 LS BMD 50 MELD scores 50 Primary endpoints 50 macroalbuminuria 50 symptomatic VTE 50 colorectal adenoma 50 coronary stenosis 50 lipid lowering therapy 50 serum aminotransferase levels 50 plasma lipids 50 International Normalized Ratio 50 apnea hypopnea 50 NovoMix ® 50 uric acid levels 50 peak plasma concentrations 50 cinacalcet 50 death reinfarction 50 logMAR 50 ABC/3TC 50 BMI #-#.# 50 beclomethasone dipropionate 50 timepoints 50 serum homocysteine 50 revascularizations 50 homocysteine concentrations 50 HDL cholesterol triglycerides 50 REMICADE monotherapy 50 ACTEMRA TM 50 elevated hsCRP 50 CsA 50 corticosteroid dose 50 DAS# remission 50 LVSD 50 abdominal pain flatulence 50 glycaemia 50 elevated triglycerides 50 transaminase elevations greater 49 OPCAB 49 plasma creatinine 49 eosinophil count 49 azacitidine 49 aspirin heparin 49 complete cytogenetic response 49 hypoxemia 49 #mg/kg [002] 49 mg/m2/day 49 lumbar spine bone 49 triglyceride concentration 49 Fasting plasma glucose 49 SCr 49 Systolic pressure 49 milliliters mL 49 haemorrhagic stroke 49 postoperative mortality 49 cisplatin vinorelbine 49 #ng/ml 49 inspiratory 49 primary efficacy endpoint 49 UKPDS 49 pooled comparator 49 left ventricular ejection 49 SHBG levels 49 CCyR 49 subclinical hyperthyroidism 49 nM 49 renal insufficiency 49 stent binary restenosis 49 carotid intima media 49 methacholine 49 XIENCE V demonstrated 49 metformin IR 49 atherosclerotic renal artery stenosis 49 TC HDL 49 aPTT 49 urinary excretion 49 μg g 49 gm dl 49 left ventricular LV 49 rheumatoid factor 49 cells mcL 49 ischemia driven 49 plus dexamethasone 49 angiotensin converting enzyme ACE 49 lipoprotein Lp 49 NCEP ATP III 49 racemic albuterol 49 venous thrombosis 49 eNO 49 advanced adenoma 49 cells/mm3 49 ACR Pedi 49 reperfusion 49 oxygen saturations 49 quetiapine 49 neurodevelopmental impairment 49 HDRS 49 NSTEMI 49 PSADT 49 LDL Cholesterol 49 overt nephropathy 49 glucose intolerant 49 -# mg dL 49 CI = 49 hypogonadal men 49 thromboembolism 49 blood glucose levels 49 hemodynamics 49 nmol L. 49 statin therapy 49 budesonide formoterol 49 mg RDEA# 49 NIHSS score 49 serum lipids 49 glycemic control 49 daunorubicin 49 #-# mg dl 49 carotid stenosis 49 recurrent DVT 49 renal dysfunction 49 abdominal circumference 49 Apgar scores 49 virologic breakthrough 49 T2DM 49 undergoing coronary artery 49 anticoagulation 49 Fasting glucose levels 49 NYHA Class III 49 Elitek 49 HIV RNA 49 headache nasopharyngitis 49 sirolimus stent 49 insulin lispro 49 anti hypertensive 49 severe hypoglycemia 49 Hazard Ratio 49 FFR guided 49 DASH diet 49 isoprostane 49 p = #.# [003] 49 mU 49 μg dl 49 mcg doses 49 nonsignificant 49 platelet aggregation 49 PANSS total 49 ivabradine 49 CVD mortality 49 spontaneous bowel movements 49 hypogonadal 49 pT3 49 arterial thickening 49 Acetate Rectal Suppositories 49 mean serum phosphorus 49 serum prostate 49 Mg Uk 49 serum transaminases 49 intramuscularly 49 aspirin clopidogrel 49 dosing frequency 49 sinus rhythm 49 urate levels 49 experienced virologic failure 49 macrovascular disease 49 renal function 49 psig 49 Fasting blood glucose 49 mg/# hours 49 Expanded Disability Status 49 mg kg Hematide 49 LDL HDL ratio 49 mg Androxal 49 lipid lowering drugs 49 brachial blood 49 detrusor overactivity 49 dyspnea